| Athens-limestone Homecare | |
| 725 West Market Street, Suite A, Athens, Alabama 35611 | |
| (256) 233-9533 | |
| Name | Athens-limestone Homecare |
|---|---|
| Location | 725 West Market Street, Suite A, Athens, Alabama |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 17095 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 35610, 35611, 35612, 35613, 35614, 35615, 35620, 35647, 35648, 35652, 35671, 35739, 35749, 35756, 35773 |
| NPI Number | 1164468377 |
| Organization Name | ATHENS LIMESTONE HEALTH SERVICES, LLC |
| Doing Business As | ATHENS LIMESTONE HOSPITAL HOME HEALTH CARE |
| Address | 661 Us Highway 72 W, Athens, AL 35611 |
| Phone Number | 256-233-9533 |
News Archive
A new paper by an international team of researchers describes experimental evidence of the antiviral efficacy of a marine compound called plitidepsin against SARS-CoV-2. The findings show that plitidepsin inhibits SARS-CoV at low concentrations, as observed by a thousand-fold reduction in genomic RNA and viral titers in cells exposed to the virus in culture when treated.
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.
Clinical factors including the time to biochemical recurrence following surgery can help predict the risk of prostate cancer death for patients following a radical prostatectomy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
› Verified 4 days ago
| NPI Number | 1730136698 |
| Organization Name | ATHENS-LIMESTONE HOMECARE, LLC |
| Doing Business As | ATHENS-LIMESTONE HOMECARE |
| Address | 725 W Market St, Suite A, Athens, AL 35611 |
| Phone Number | 256-233-9533 |
News Archive
A new paper by an international team of researchers describes experimental evidence of the antiviral efficacy of a marine compound called plitidepsin against SARS-CoV-2. The findings show that plitidepsin inhibits SARS-CoV at low concentrations, as observed by a thousand-fold reduction in genomic RNA and viral titers in cells exposed to the virus in culture when treated.
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.
Clinical factors including the time to biochemical recurrence following surgery can help predict the risk of prostate cancer death for patients following a radical prostatectomy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
› Verified 4 days ago
| Quality Rating: |
News Archive
A new paper by an international team of researchers describes experimental evidence of the antiviral efficacy of a marine compound called plitidepsin against SARS-CoV-2. The findings show that plitidepsin inhibits SARS-CoV at low concentrations, as observed by a thousand-fold reduction in genomic RNA and viral titers in cells exposed to the virus in culture when treated.
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.
Clinical factors including the time to biochemical recurrence following surgery can help predict the risk of prostate cancer death for patients following a radical prostatectomy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.9 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 99.9 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 88.6 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 90.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.8 | 96.4 |
News Archive
A new paper by an international team of researchers describes experimental evidence of the antiviral efficacy of a marine compound called plitidepsin against SARS-CoV-2. The findings show that plitidepsin inhibits SARS-CoV at low concentrations, as observed by a thousand-fold reduction in genomic RNA and viral titers in cells exposed to the virus in culture when treated.
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.
Clinical factors including the time to biochemical recurrence following surgery can help predict the risk of prostate cancer death for patients following a radical prostatectomy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 86.5 | 79.6 |
| How often patients got better at getting in and out of bed | 90.4 | 81.1 |
| How often patients got better at bathing | 88.2 | 82.3 |
| How often patients’ breathing improved | 86.7 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 95.5 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 85.4 | 75 |
| How often home health patients had to be admitted to the hospital | 15.5 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.2 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.5 | 94 |
News Archive
A new paper by an international team of researchers describes experimental evidence of the antiviral efficacy of a marine compound called plitidepsin against SARS-CoV-2. The findings show that plitidepsin inhibits SARS-CoV at low concentrations, as observed by a thousand-fold reduction in genomic RNA and viral titers in cells exposed to the virus in culture when treated.
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.
Clinical factors including the time to biochemical recurrence following surgery can help predict the risk of prostate cancer death for patients following a radical prostatectomy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
› Verified 4 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
A new paper by an international team of researchers describes experimental evidence of the antiviral efficacy of a marine compound called plitidepsin against SARS-CoV-2. The findings show that plitidepsin inhibits SARS-CoV at low concentrations, as observed by a thousand-fold reduction in genomic RNA and viral titers in cells exposed to the virus in culture when treated.
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.
Clinical factors including the time to biochemical recurrence following surgery can help predict the risk of prostate cancer death for patients following a radical prostatectomy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
› Verified 4 days ago
The patient survey data of Athens-limestone Homecare is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 90 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 81 | 78 |
News Archive
A new paper by an international team of researchers describes experimental evidence of the antiviral efficacy of a marine compound called plitidepsin against SARS-CoV-2. The findings show that plitidepsin inhibits SARS-CoV at low concentrations, as observed by a thousand-fold reduction in genomic RNA and viral titers in cells exposed to the virus in culture when treated.
Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.
The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.
Clinical factors including the time to biochemical recurrence following surgery can help predict the risk of prostate cancer death for patients following a radical prostatectomy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.
V.I. Technologies (Vitex) and collaborators at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, today presented a detailed analysis of the Phase I/II clinical trial of its HIV drug candidate PA-457 at the 3rd International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment in Rio de Janeiro, Brazil.
› Verified 4 days ago
Athens-limestone Homecare Location: 725 West Market Street, Suite A, Athens, Alabama 35611 Ratings: Phone: (256) 233-9533 |